PlainRecalls
FDA Devices Moderate Class II Terminated

Turbo Troponin I For in vitro diagnostic use for the quantitative measurement of troponin I in serum, heparinized or EDTA plasma, as an aid in the diagnosis of acute myocardial infarction (AMI).

Reported: December 24, 2014 Initiated: October 27, 2014 #Z-0801-2015

Product Description

Turbo Troponin I For in vitro diagnostic use for the quantitative measurement of troponin I in serum, heparinized or EDTA plasma, as an aid in the diagnosis of acute myocardial infarction (AMI).

Details

Units Affected
3,622 kits (3,572 domestic and 50 internationally)
Distribution
Worldwide Distribution: US distribution in states of: CO, FL, MN, MT, and NY; and countries of: Algeria, Argentina, Bolivia, Brazil, Bulgaria, Chile, Columbia, Czech Republic, Ecuador, Egypt, Germany, Hungary, India, Italy, Lithuania, Latvia, Pakistan, Poland, Romania, Russian Fed., Serbia, South Africa, Slovakia, Thailand, Tunisia, and Uruguay.
Location
Tarrytown, NY

Frequently Asked Questions

What product was recalled?
Turbo Troponin I For in vitro diagnostic use for the quantitative measurement of troponin I in serum, heparinized or EDTA plasma, as an aid in the diagnosis of acute myocardial infarction (AMI).. Recalled by Siemens Healthcare Diagnostics, Inc.. Units affected: 3,622 kits (3,572 domestic and 50 internationally).
Which agency issued this recall?
This recall was issued by the FDA Devices on December 24, 2014. Severity: Moderate. Recall number: Z-0801-2015.